Search

Displaying results 5461 - 5470 of 10000 in total
  1. Drug

    Stevaladil

    go.drugbank.com/drugs/DB20689
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Stevaladil is a vasodilator. Stevaladil has a monoisotopic molecular weight of 447.33 Da.

  2. Drug

    Meluadrine

    go.drugbank.com/drugs/DB20693
    Experimental

    The usage of the INN stem '-drine' in the name indicates that Meluadrine is a sympathomimetic. Meluadrine has a monoisotopic molecular weight of 243.1 Da.

  3. Drug

    Bamirastine

    go.drugbank.com/drugs/DB21186
    Experimental

    The usage of the INN stem '-astine' in the name indicates that Bamirastine is a antihistaminic. Bamirastine has a monoisotopic molecular weight of 527.29 Da.

  4. Drug

    Barmastine

    go.drugbank.com/drugs/DB21253
    Experimental

    The usage of the INN stem '-astine' in the name indicates that Barmastine is a antihistaminic. Barmastine has a monoisotopic molecular weight of 483.24 Da.

  5. Drug

    Zanoterone

    go.drugbank.com/drugs/DB21384
    Experimental

    The usage of the INN stem '-terone' in the name indicates that Zanoterone is a antiandrogen. Zanoterone has a monoisotopic molecular weight of 416.21 Da.

  6. Drug

    OMS-103HP

    go.drugbank.com/drugs/DB05303
    Investigational

    OMS103HP is the first drug being developed to improve joint function following arthroscopic surgery, one of the most common procedures performed today by orthopedic surgeons.

  7. Drug

    Oxypurinol

    go.drugbank.com/drugs/DB05262
    Investigational

    Oxypurinol, an inhibitor of xanthine oxidase, is a metabolite of allopurinol.

    Synonyms: 1H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione
  8. Drug

    Olcegepant

    go.drugbank.com/drugs/DB04869
    Investigational

    Boehringer Ingelheim Pharmaceuticals’ olcegepant (BIBN 4096) is a selective Calcitonin Gene-Related Peptide (CGRP) antagonist, a new class of drugs in development for the treatment of acute migraine attacks … Olcegepant is undergoing phase II trials in Europe and the US, with preliminary results suggesting that CGRP antagonists may represent a potential new approach to the treatment of migraine.

  9. Drug

    Dilmapimod

    go.drugbank.com/drugs/DB12140
    Investigational

    Dilmapimod has been used in trials studying the treatment and diagnostic of Nerve Trauma, Inflammation, Pain, Neuropathic, Arthritis, Rheumatoid, and Coronary Heart Disease, among others. … Dilmapimod (SB-681323) is a p38 MAP-kinase inhibitor that has potential uses in inflammatory conditions such as RA (Rheumatoid Arthritis).

  10. Drug

    RTP-801i

    go.drugbank.com/drugs/DB06048
    Investigational

    The proposed primary indication for RTP-801i is the treatment of patients with neovascular (wet) Age-related Macular Degeneration (AMD or ARMD). … RTP-801i is an siRNA drug candidate designed to inhibit the expression of the hypoxia-inducible gene RTP801.